The impact of primary diseases is substantial, demanding groundbreaking therapeutic options. Cellular therapies represent a especially promising avenue, offering the chance to regenerate damaged hepatic tissue and improve therapeutic outcomes. Currently, research focuses on several approaches, including the introduction of mesenchymal cellular enti